Sally A. Berry, MD, PhD
Sally A. Berry, MD, PhD
Pfizer Inc.
EPBU
235 E 42nd St
New York,
NY
USA
10017
Papers:
3.32
Time-Course of Treatment-Emergent Adverse Events Following Administration of an Extended-Release Methylphenidate Oral Suspension